CCL2 and inflammatory bowel disease: Other studies demonstrated a reduction in CCL2 using L. paracasei-derived postbiotics in an in vitro inflammatory bowel disease model [49] or found that cell-free supernatants from different species (e.g., L. acidophilus) downregulated IL-8 expression in HT-29 cells [50].